Skip to main content
Premium Trial:

Request an Annual Quote

Three RNAi-Related Patent Applications Published By US Patent Office

Premium

Title: RNA Interference-Mediated Inhibition of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid. Number: 20050032733. Filed: April 16, 2004. Lead Inventor: James McSwiggen, Sirna Therapeutics.

The invention, the patent application’s abstract states, “concerns methods and reagents useful in modulating gene expression in a variety of applications, including use in therapeutic, diagnostic, target validation, and genomic discovery applications. Specifically, the invention relates to synthetic chemically modified small nucleic acid molecules, such as short-interfering nucleic acid, short interfering RNA, double-stranded RNA, microRNA, and short hairpin RNA molecules capable of mediating RNA interference against target nucleic acid sequences.

“The small nucleic acid molecules are useful in the treatment of any disease or condition that responds to modulation of gene expression or activity in a cell, tissue, or organism,” the abstract adds.


Title: Oligomeric Compounds Having Modified Bases for Binding to Adenine and Guanine and Their Use in Gene Modulation. Number: 20050032069. Filed: Aug. 6, 2003. Lead Inventor: Muthiah Manoharan, Alnylam Pharmaceuticals.

According to its abstract, the patent application covers “oligomer compositions comprising first and second oligomers … wherein at least a portion of the first oligomer is capable of hybridizing with at least a portion of the second oligomer; at least a portion of the first oligomer is complementary to and capable of hybridizing to a selected target nucleic acid; and at least one of the first or second oligomers has a modified base for binding to an adenine or guanine base in the opposite strand.”

The abstract adds that “oligonucleotide/protein compositions are also provided comprising an oligomer complementary to and capable of hybridizing to a selected target nucleic acid and at least one protein comprising at least a portion of an RNA-induced silencing complex, wherein the oligomer has a modified base for binding to an adenine or guanine base in the opposite strand.”


Title: Sugar and Backbone-Surrogate-Containing Oligomeric Compounds and Compositions for Use in Gene Modulation. Number: 20050032068. Filed: Aug. 5, 2003. Lead Inventor: Thazha Prakash, Isis Pharmaceuticals (Alnylam Pharmaceuticals).

The patent application, its abstract states, covers “compositions comprising first and second oligomers … wherein at least a portion of the first oligomer is capable of hybridizing with at least a portion of the second oligomer; at least a portion of the first oligomer is complementary to and capable of hybridizing to a selected target nucleic acid; and at least one of the first or second oligomers includes a modified sugar and/or backbone modification.

“In some embodiments the modification is a peptide nucleic acid, a peptide nucleic acid mimic, a morpholino nucleic acid, hexose sugar with amide linkage, cyclohexenyl nucleic acid, or an acyclic backbone moiety,” the abstract states. “Oligomer/protein compositions are also provided comprising an oligomer complementary to and capable of hybridizing to a selected target nucleic acid and at least one protein comprising at least a portion of an RNA-induced silencing complex, wherein at least one nucleotide of the oligomer has a modified sugar and/or backbone modification.”

 

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.